Platelet and neutrophil activation in cardiopulmonary bypass.
My colleagues and I have employed a simulated extracorporeal circuit to help define blood cell changes during clinical cardiopulmonary bypass. Platelet count decreases sharply due to temporary adhesion to the circuit. Platelets degranulate, synthesize and release thromboxane A2, and lose the ability to aggregate with adenosine diphosphate and epinephrine. These changes are also due to the loss of alpha 2-adrenergic and fibrinogen receptors. The neutrophil count decreases to a lesser extent, but neutrophils also are stimulated to secrete lactoferrin and elastase concomitant with activation of plasma kallikrein. Although lidocaine can inhibit the neutrophil activation and prostacyclin can inhibit the platelet stimulation, prostaglandin E1 appears to prevent both neutrophil and platelet alterations.
Colman
R W
RW
Thrombosis Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.
D002315:Cardiopulmonary Bypass / Q000295:instrumentation; D006801:Humans; D009504:Neutrophils / Q000502:physiology*; D015539:Platelet Activation / Q000502:physiology*; D013499:Surface Properties